11TU | pdb_000011tu

Crystal structure of alpha/beta-hydrolase macrolide esterase EstT from Bacillus cereus (S102A mutant) in complex with linearized tylvalosin


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free: 
    0.201 (Depositor), 0.201 (DCC) 
  • R-Value Work: 
    0.178 (Depositor), 0.178 (DCC) 
  • R-Value Observed: 
    0.179 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 11TU

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Hydration and hydrolysis define antibiotic resistance conferred by macrolide esterases.

Kelly, E.T.R.Myziuk, I.Hemmings, M.Z.Mulla, Z.Blanchet, J.Ruzzini, A.Berghuis, A.M.

(2026) Proc Natl Acad Sci U S A 123: e2611077123-e2611077123

  • DOI: https://doi.org/10.1073/pnas.2611077123
  • Primary Citation Related Structures: 
    11TS, 11TT, 11TU, 11TV, 11TW

  • PubMed Abstract: 

    Macrolides are an antibiotic class widely used in both human and veterinary medicine, and function by interfering with protein synthesis. Regrettably, numerous strategies for evading the antibiotic properties of macrolides have been found in bacteria, including enzyme-mediated inactivation. These mechanisms are now widely disseminated among pathogenic, animal-associated, and environmental bacteria making them a One Health issue. Macrolide esterases, which hydrolyze the macrolactone's ester bond, confer one such resistance mechanism. Two types of macrolide esterases have thus far been identified, the well-studied erythromycin esterases and the recently discovered Est-type enzymes that belong to the α/β-hydrolase superfamily. We present detailed structure-function studies for four diverse Est type esterases: which only share 44 to 66% sequence identity (EstT Sf , EstT St , EstT Bc , and EstX Ec ). In addition to resistance profiling and substrate specificity studies, we present structures for all four enzymes, including structures for EstT Bc and EstX Ec in complex with tylosin and tylvalosin macrolides, posthydrolysis. Complementing the data with mutational and kinetic studies allowed for a detailed analysis of the structural basis for macrolide-enzyme interactions. Combined, the data suggest that promiscuous binding and imprecise positioning, mediated by a water-cage, dictate substrate specificity for Est-type macrolide resistance enzymes. These insights may prove beneficial for next-generation antibiotic development.


  • Organizational Affiliation
    • Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada.

Macromolecule Content 

  • Total Structure Weight: 32.57 kDa 
  • Atom Count: 2,356 
  • Modeled Residue Count: 270 
  • Deposited Residue Count: 284 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
alpha/beta-hydrolase macrolide esterase EstT284Bacillus cereusMutation(s): 1 
Gene Names: CN307_07515
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1DAR
(Subject of Investigation/LOI)

Query on A1DAR



Download:Ideal Coordinates CCD File
B [auth A]linearized tylvalosin
C53 H93 N O20
WXLGBWASBIONQW-NJIHMORWSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free:  0.201 (Depositor), 0.201 (DCC) 
  • R-Value Work:  0.178 (Depositor), 0.178 (DCC) 
  • R-Value Observed: 0.179 (Depositor) 
Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 72.492α = 90
b = 72.492β = 90
c = 129.214γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
HKL-2000data reduction
SCALEPACKdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Canadian Institutes of Health Research (CIHR)CanadaPJT-162365

Revision History  (Full details and data files)

  • Version 1.0: 2026-04-08
    Type: Initial release
  • Version 1.1: 2026-07-29
    Changes: Database references